SGLT2 Inhibitors Cut Liver Fat in MASLD
Author Summary

SGLT2 Inhibitors Cut Liver Fat in MASLD

July 25, 2025 0

Effect of SGLT2 inhibitors on liver fat content: A meta-analysis A growing metabolic challenge Metabolic dysfunction–associated steatotic liver disease (MASLD)—formerly called non-alcoholic fatty liver disease (NAFLD)—now affects about one-third of the global population. Like NAFLD, […]

SGLT2 Inhibitors May Lower Cardiac Risk from Cancer Therapy
Author Summary

SGLT2 Inhibitors May Lower Cardiac Risk from Cancer Therapy

May 19, 2025 0

Understanding Cancer Therapy-Related Cardiac Dysfunction Cancer therapy-related cardiac dysfunction (CTRCD) is an increasingly recognized consequence of many life-saving cancer treatments. Defined as a drop in left ventricular ejection fraction (LVEF) greater than 10%, often with […]